ArticleTherapeutic advances in endocrinology and metabolism2021

Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM.

Aml Mohamed Nada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.